CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Montreal, Quebec, Canada and 73 other locations
This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...
Phase 3
Montreal, Quebec, Canada and 161 other locations
(IV) (Part 1) and subcutaneous (SC) (Part 2) doses of RO7121932 and multiple ascending SC (Part 3) doses of RO7121932 in participants with m ...
Phase 1
Montreal, Quebec, Canada and 23 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Granby, Quebec, Canada and 33 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Montreal, Quebec, Canada and 229 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
Montreal, Quebec, Canada and 60 other locations
Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple...
Phase 2
Montréal, Canada and 72 other locations
Primary Objective:To determine the long-term safety and tolerability of SAR442168 in RMS participantsSecondary Objective:To evaluate efficacy of SAR4...
Phase 2
Greenfield Park, Canada and 36 other locations
The primary purpose of this study is to evaluate the safety and tolerability of VRG50635 in participants with ALS.
Phase 1
Montreal, Quebec, Canada and 1 other location
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...
Phase 3
Montreal, Quebec, Canada and 125 other locations
Clinical trials
Research sites
Resources
Legal